Cargando…
The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells
Adriamycin (ADR) induces the over-expression of P-glycoprotein (P-gp) and multiple drug resistance in breast cancer cells. However, the biochemical process and underlying mechanisms are not clear. Our previous study revealed that ADR increased reactive oxygen species (ROS) generation and decreased g...
Autores principales: | Ge, Chun, Cao, Bei, Feng, Dong, Zhou, Fang, Zhang, Jingwei, Yang, Na, Feng, Siqi, Wang, Guangji, Aa, Jiye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476638/ https://www.ncbi.nlm.nih.gov/pubmed/28630426 http://dx.doi.org/10.1038/s41598-017-03881-9 |
Ejemplares similares
-
The Role of SLC7A11 in Cancer: Friend or Foe?
por: Li, Sijia, et al.
Publicado: (2022) -
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
por: Shao, Wenna, et al.
Publicado: (2023) -
Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation
por: Guan, Zhenhua, et al.
Publicado: (2020) -
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
por: Wang, Changyuan, et al.
Publicado: (2016) -
Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction
por: Wang, Wenjie, et al.
Publicado: (2017)